EuroMEEting - Genetic Alliance UK

More documents

Recommendations

Info

6 OPENING PLENARY O P E N I N G P L E N A R Y GENEVA 2011 Monday, 28 March 2011 | 14:00 - 17:15 The 23rd Annual DIA EuroMeeting 2011 opens at a time of unprecedented change and challenge for the pharmaceutical industry, academia and regulators – in a climate of great expectations for groundbreaking scientific innovation, efficient cost-effective delivery, high standards of patient protection, excellent communication and transparency and best value for payers as well as patients and professionals. In the international city of Geneva it is right that we should be thinking beyond the boundaries of Europe. We should be building bridges, removing old boundaries: there is no doubt that the time has truly come for all stakeholders to work together in the best interests of public health. It is time for clearly defined goals, commonality of purpose and above all for visionary leadership. Where should our priorities be, and how can these enormous challenges become opportunities? It is therefore fitting that the EuroMeeting 2011 should begin with a Keynote Address from Commissioner John Dalli of DG SANCO. Commissioner Dalli will share his vision for optimising the health of the 500 million citizens of Europe and the part to be played by pharmaceuticals in achieving this. Following the move of the responsibility for pharmaceuticals from DG Enterprise to DG SANCO it is a unique opportunity to look ahead. This vision will be a framework for the themes and sessions of the Euromeeting to follow, and a context for the detailed discussions over the following days. In these exciting times, discussion must be challenging as well as reflective, stimulating and informative. So what better time than now to get down to reality, and listen to leaders in their fields debate. Come and join us in the plenary, participate in the debate and cast your vote! Keynote Address John Dalli European Commissioner responsible for Health and Consumer Policy John Dalli started to serve as a Cabinet Minister in the Maltese Government in 1987 having been first elected to the House of Representatives of Malta on behalf of the Nationalist Party in 1987. He served as Parliamentary Secretary for Industry (1987-1990), Minister of Economic Affairs (1990-92), Minister of Finance (1992-1996, 1998-2003), Minister of Finance and Economic Affairs and Minister of Foreign Affairs and Investment Promotion (2004). Between March 2008 and February 2010, John Dalli served as Minister for Social Policy which includes the health, housing, employment and industrial relations portfolio. Oxford Debate There will also be an “Oxford Debate” following the University of Oxford’s eminent tradition. The working title for the debate is: "The current regulatory system does not support timely patient access to beneficial medicines". Moderator Hans-Georg Eichler, Senior Medical Officer, European Medicines Agency, EU Debaters Andrew Dillon, Chief Executive, NICE, <strong>UK</strong> Peter Bonne Eriksen, Senior Vice President, Global Regulatory Affairs, Novo Nordisk, Denmark Greetje Goossens, Counseler, European Myeloma Platform, The Netherlands Jean Marimbert, Director-General, AFSSAPS, France As a qualified accountant, Dalli also worked in the private sector in Malta and abroad, both in industry and as an independent consultant. In February 2010 John Dalli was appointed European Commissioner responsible for Health and Consumer Policy.
SPECIAL SESSIONS 7 This is the advance programme. New speakers and sessions will be added. Visit www.diahome.org for the most recent additions to the programme. Student Sessions Session 1701 | Monday, 28 March 2011 | 09:00-09:40 PRESENT WITH CONFIDENCE WORKSHOP Instructor: Judy Churchill, Communication Skills Specialist, France Session 1702 | Monday, 28 March 2011 | 09:50-10:30 CURRICULUM VITAE WORKSHOP Instructor: To be confirmed Students attending this workshop will receive tips and advice on creating a winning CV. Session 1703 | Monday, 28 March 2011 | 11:00-12:30 DIA STUDENT CHAPTER SESSION 2015 Roadmap Session Session 1603 | Tuesday, 29 March 2011 | 14:00-15:30 Session Chair: Noel Wathion, Head of Public Health Protection, European Medicines Agency, EU On 26 January 2010, the European Medicines Agency published a draft paper setting out its vision for the strategic development of the Agency for the five years to 2015. Building on the progress of its previous five-year strategy, the Road Map to 2015 charts the way forward for the Agency amid rapid developments in medical science and pharmaceutical research, as well as the continuing evolution of the European and international regulatory environments. With this strategy paper to guide it, the Agency will seek to consolidate its achievements to date and further strengthen its role as a guardian of human and animal health in the European Union. Emer Cooke, International Liaison Officer, European Medicines Agency, EU in partnership with the European Pharmaceutical Students’ Association (EPSA) and the International Federation of Medical Students’ Associations (IFMSA). All student participants are invited to join an informal networking and information session in which they can learn more about a range of professional disciplines in the pharmaceutical world: What do they involve? What is the best way in? What are the challenges and the opportunities? Taking the innovative form of an interactive attendee-led “unconference”, which does not have any agenda, speakers or presentations, participants begin by discussing what they would like to get out of the session and what topics of interest they would like to see covered. A group of experienced professionals from a range of pharmaceutical backgrounds will lead small groups of students in discussion around the room. There will be an open format and students may move from one group to another. Young Professionals Session Session 1800 | Monday, 28 March 2011 | 11:00-12:30 Session Chair: Estelle Michael, Senior Manager Regulatory Policy and Intelligence, GlaxoSmithKline, Biologicals, Belgium Currently under development. Heads of Medicines Agencies Session Session 1602 | Tuesday, 29 March 2011 | 11:00-12:30 Session Chair: Kent Woods, Chief Executive, MHRA, <strong>UK</strong> Jean Marimbert, General Director, Afssaps, France Jytte Lyngvig, Chief Executive Officer, Danish Medicines Agency, Denmark Session under development Town Hall Meeting Session 0206 | Wednesday, 30 March 2011 | 11:00-12:30 MEET THE REGULATORS Moderator: Christa Wirthumer-Hoche, Deputy Head, AGES PharmMed, Austria The Town Hall Meeting is an open interactive session where participants can ask key decision makers in the European Regulatory system burning questions. The panel will include representatives from the European Medicines Agency, National Competent Authorities and a patient organisation. The topics/questions discussed are decided by the attendees and should be related to: • Responsibility of the Agencies in the EU network • Authorisation and Maintenance of Medicinal Products; Benefit/Risk Methodologies • Pharmacovigilance • International Cooperation and Inspection-Related Issues • Electronic Submission • The Role of Patient Organisations Responsibilities of the Agencies in the EU Network Noel Wathion, Head of Public Health Protection, European Medicines Agency, EU Aginus Kalis, Chair HMA-MG, Executive Director, Medicines Evaluation Board (MEB), The Netherlands Authorisation and Maintenance of Medicinal Products; Benefit/Risk Methodologies Hans-Georg Eichler, Senior Medical Officer, European Medicines Agency, EU Eric Abadie, Chair CHMP, Chair Pharmacogenomics Working Party, General Director, Afssaps, France Truus Janse-de Hoog , Chair CMD(h), Staff member MEB, European cluster, Medicines Evaluation Board, The Netherlands Aginus Kalis, Executive Director, Medicines Evaluation Board (MEB), The Netherlands Marcus Muellner, Director, AGES PharmMed, Austria
Page 1 and 2: EuroMEEting gEnEva 2011 28-30 March
Page 3 and 4: EUROMEETING 2011 CO-CHAIRS’ MESSA
Page 5: PLAN YOUR EUROMEETING EXPERIENCE 5
Page 9 and 10: DIA FELLOWSHIPS 9 This is the advan
Page 11 and 12: TUTORIALS 11 This is the advance pr
Page 13 and 14: TUTORIALS 13 This is the advance pr
Page 15 and 16: GREENING THE EUROMEETING 15 GREENIN
Page 17 and 18: THEME 1 | THEME 2 17 This is the ad
Page 19 and 20: THEME 2 19 This is the advance prog
Page 33 and 34: THEME 10 33 This is the advance pro
Page 37 and 38: THEME 12 | THEME 13 37 This is the
Page 39 and 40: THEME 13 | THEME 14 39 This is the
Page 43 and 44: HOT TOPICS | STAND ALONE SESSIONS 4
Page 45 and 46: ABOUT GENEVA 45 This is the advance
Page 47 and 48: ACCOMMODATION AND TRANSPORT 47 This
Page 49 and 50: D I A 2011 Convergence of Science M
Page 51 and 52: Lunch Lunch 23RD ANNUAL EUROMEETING
Page 53 and 54: EuroMeeting Key Contacts Go to the

EuroMEEting - Genetic Alliance UK

Create successful ePaper yourself

Delete template?

Save as template?